Carcinogenicity of cardiovascular drugs
Author:
Publisher
Springer Science and Business Media LLC
Subject
Internal Medicine
Link
http://link.springer.com/content/pdf/10.1007/s11906-999-0023-8.pdf
Reference73 articles.
1. MRC Working Party: Medical Research Council trial of treatment of hypertension in older adults:principal results. BMJ 1992, 304:405–411.
2. Staessen J, Bulpitt C, Clement D, et al.: Relation between mortality and treated blood pressure in elderly patients with hypertension: report of the European Working Party on High Blood Pressure in the Elderly. BMJ 1989, 298:1552–1556.
3. SHEP Cooperative Ressearch Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991, 265:3255–3264.
4. Williams RR, Feinleib M, Connor RJ, Stegens NL: Case-controlled study of antihypertensive and diuretic use by women with malignant and benign breast lesions detected in a mammography screening program. J Natl Cancer Inst 1978, 61:327–335.
5. Fraser GE, Phillips RL, Beeson WL: Hypertension, antihypertensive medication, and risk of renal carcinoma in California Seventh-Day Adventists. Int J Epidemiol 1990, 19:832–838.
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Assessment of DNA Damage in Leukocytes of Patients With Coronary Artery Disease by Comet Assay;International Heart Journal;2017
2. Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literature;Expert Opinion on Drug Safety;2014-07-05
3. Angiotensin receptor blocker therapy and risk of cancer;Journal of Hypertension;2013-08
4. Arterial hypertension and cancer;International Journal of Cancer;2013-07-31
5. Angiotensin Receptor Blockers and Tumorigenesis: Something To Be (or Not To Be) Concerned About?;Current Hypertension Reports;2012-04-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3